Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay
BackgroundSalivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific reference ranges for an automated electrochemiluminescence immunoassay (ECLIA).MethodsUnstimulated saliva from 62 patients with hypothalamic–pituitar...
Saved in:
Published in | European journal of endocrinology Vol. 166; no. 4; pp. 613 - 618 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Bristol
BioScientifica
01.04.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | BackgroundSalivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific reference ranges for an automated electrochemiluminescence immunoassay (ECLIA).MethodsUnstimulated saliva from 62 patients with hypothalamic–pituitary disease was collected at 0800 h. A peak serum cortisol level below 500 nmol/l during the insulin tolerance test (ITT) was used to identify hypocortisolism. Receiver-operating characteristic (ROC) analysis allowed establishment of lower and upper cutoffs with at least 95% specificity for adrenal insufficiency and adrenal sufficiency. Saliva from 40 patients with confirmed hypercortisolism, 45 patients with various adrenal masses, and 115 healthy subjects was sampled at 2300 h and after low-dose dexamethasone suppression at 0800 h. ROC analysis was used to calculate thresholds with at least 95% sensitivity for hypercortisolism. Salivary cortisol was measured with an automated ECLIA.ResultsWhen screening for secondary adrenal insufficiency, a lower cutoff of 3.2 nmol/l and an upper cutoff of 13.2 nmol/l for unstimulated salivary cortisol allowed a highly specific diagnosis (i.e. similar to the ITT result) in 26% of patients. For identification of hypercortisolism, cutoffs of 6.1 nmol/l (sensitivity 95%, specificity 91%, area under the curve (AUC) 0.97) and 2.0 nmol/l (sensitivity 97%, specificity 86%, AUC 0.97) were established for salivary cortisol at 2300 h and for dexamethasone-suppressed salivary cortisol at 0800 h.ConclusionsThe newly established thresholds facilitated initial screening for secondary adrenal insufficiency and allowed excellent identification of hypercortisolism. Measurement by an automated immunoassay will allow broader use of salivary cortisol as a diagnostic tool. |
---|---|
AbstractList | BackgroundSalivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific reference ranges for an automated electrochemiluminescence immunoassay (ECLIA).MethodsUnstimulated saliva from 62 patients with hypothalamic–pituitary disease was collected at 0800 h. A peak serum cortisol level below 500 nmol/l during the insulin tolerance test (ITT) was used to identify hypocortisolism. Receiver-operating characteristic (ROC) analysis allowed establishment of lower and upper cutoffs with at least 95% specificity for adrenal insufficiency and adrenal sufficiency. Saliva from 40 patients with confirmed hypercortisolism, 45 patients with various adrenal masses, and 115 healthy subjects was sampled at 2300 h and after low-dose dexamethasone suppression at 0800 h. ROC analysis was used to calculate thresholds with at least 95% sensitivity for hypercortisolism. Salivary cortisol was measured with an automated ECLIA.ResultsWhen screening for secondary adrenal insufficiency, a lower cutoff of 3.2 nmol/l and an upper cutoff of 13.2 nmol/l for unstimulated salivary cortisol allowed a highly specific diagnosis (i.e. similar to the ITT result) in 26% of patients. For identification of hypercortisolism, cutoffs of 6.1 nmol/l (sensitivity 95%, specificity 91%, area under the curve (AUC) 0.97) and 2.0 nmol/l (sensitivity 97%, specificity 86%, AUC 0.97) were established for salivary cortisol at 2300 h and for dexamethasone-suppressed salivary cortisol at 0800 h.ConclusionsThe newly established thresholds facilitated initial screening for secondary adrenal insufficiency and allowed excellent identification of hypercortisolism. Measurement by an automated immunoassay will allow broader use of salivary cortisol as a diagnostic tool. Salivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific reference ranges for an automated electrochemiluminescence immunoassay (ECLIA). Unstimulated saliva from 62 patients with hypothalamic-pituitary disease was collected at 0800 h. A peak serum cortisol level below 500 nmol/l during the insulin tolerance test (ITT) was used to identify hypocortisolism. Receiver-operating characteristic (ROC) analysis allowed establishment of lower and upper cutoffs with at least 95% specificity for adrenal insufficiency and adrenal sufficiency. Saliva from 40 patients with confirmed hypercortisolism, 45 patients with various adrenal masses, and 115 healthy subjects was sampled at 2300 h and after low-dose dexamethasone suppression at 0800 h . ROC analysis was used to calculate thresholds with at least 95% sensitivity for hypercortisolism. Salivary cortisol was measured with an automated ECLIA. When screening for secondary adrenal insufficiency, a lower cutoff of 3.2 nmol/l and an upper cutoff of 13.2 nmol/l for unstimulated salivary cortisol allowed a highly specific diagnosis (i.e. similar to the ITT result) in 26% of patients. For identification of hypercortisolism, cutoffs of 6.1 nmol/l (sensitivity 95%, specificity 91%, area under the curve (AUC) 0.97) and 2.0 nmol/l (sensitivity 97%, specificity 86%, AUC 0.97) were established for salivary cortisol at 2300 h and for dexamethasone-suppressed salivary cortisol at 0800 h. The newly established thresholds facilitated initial screening for secondary adrenal insufficiency and allowed excellent identification of hypercortisolism. Measurement by an automated immunoassay will allow broader use of salivary cortisol as a diagnostic tool. Salivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific reference ranges for an automated electrochemiluminescence immunoassay (ECLIA).BACKGROUNDSalivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific reference ranges for an automated electrochemiluminescence immunoassay (ECLIA).Unstimulated saliva from 62 patients with hypothalamic-pituitary disease was collected at 0800 h. A peak serum cortisol level below 500 nmol/l during the insulin tolerance test (ITT) was used to identify hypocortisolism. Receiver-operating characteristic (ROC) analysis allowed establishment of lower and upper cutoffs with at least 95% specificity for adrenal insufficiency and adrenal sufficiency. Saliva from 40 patients with confirmed hypercortisolism, 45 patients with various adrenal masses, and 115 healthy subjects was sampled at 2300 h and after low-dose dexamethasone suppression at 0800 h . ROC analysis was used to calculate thresholds with at least 95% sensitivity for hypercortisolism. Salivary cortisol was measured with an automated ECLIA.METHODSUnstimulated saliva from 62 patients with hypothalamic-pituitary disease was collected at 0800 h. A peak serum cortisol level below 500 nmol/l during the insulin tolerance test (ITT) was used to identify hypocortisolism. Receiver-operating characteristic (ROC) analysis allowed establishment of lower and upper cutoffs with at least 95% specificity for adrenal insufficiency and adrenal sufficiency. Saliva from 40 patients with confirmed hypercortisolism, 45 patients with various adrenal masses, and 115 healthy subjects was sampled at 2300 h and after low-dose dexamethasone suppression at 0800 h . ROC analysis was used to calculate thresholds with at least 95% sensitivity for hypercortisolism. Salivary cortisol was measured with an automated ECLIA.When screening for secondary adrenal insufficiency, a lower cutoff of 3.2 nmol/l and an upper cutoff of 13.2 nmol/l for unstimulated salivary cortisol allowed a highly specific diagnosis (i.e. similar to the ITT result) in 26% of patients. For identification of hypercortisolism, cutoffs of 6.1 nmol/l (sensitivity 95%, specificity 91%, area under the curve (AUC) 0.97) and 2.0 nmol/l (sensitivity 97%, specificity 86%, AUC 0.97) were established for salivary cortisol at 2300 h and for dexamethasone-suppressed salivary cortisol at 0800 h.RESULTSWhen screening for secondary adrenal insufficiency, a lower cutoff of 3.2 nmol/l and an upper cutoff of 13.2 nmol/l for unstimulated salivary cortisol allowed a highly specific diagnosis (i.e. similar to the ITT result) in 26% of patients. For identification of hypercortisolism, cutoffs of 6.1 nmol/l (sensitivity 95%, specificity 91%, area under the curve (AUC) 0.97) and 2.0 nmol/l (sensitivity 97%, specificity 86%, AUC 0.97) were established for salivary cortisol at 2300 h and for dexamethasone-suppressed salivary cortisol at 0800 h.The newly established thresholds facilitated initial screening for secondary adrenal insufficiency and allowed excellent identification of hypercortisolism. Measurement by an automated immunoassay will allow broader use of salivary cortisol as a diagnostic tool.CONCLUSIONSThe newly established thresholds facilitated initial screening for secondary adrenal insufficiency and allowed excellent identification of hypercortisolism. Measurement by an automated immunoassay will allow broader use of salivary cortisol as a diagnostic tool. |
Author | Mann, Klaus Jaeger, Andrea Deutschbein, Timo Althoff, Ricarda Walz, Martin K Petersenn, Stephan Broecker-Preuss, Martina Flitsch, Jörg |
Author_xml | – sequence: 1 givenname: Timo surname: Deutschbein fullname: Deutschbein, Timo – sequence: 2 givenname: Martina surname: Broecker-Preuss fullname: Broecker-Preuss, Martina – sequence: 3 givenname: Jörg surname: Flitsch fullname: Flitsch, Jörg – sequence: 4 givenname: Andrea surname: Jaeger fullname: Jaeger, Andrea – sequence: 5 givenname: Ricarda surname: Althoff fullname: Althoff, Ricarda – sequence: 6 givenname: Martin K surname: Walz fullname: Walz, Martin K – sequence: 7 givenname: Klaus surname: Mann fullname: Mann, Klaus – sequence: 8 givenname: Stephan surname: Petersenn fullname: Petersenn, Stephan |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25826709$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22214924$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1rFTEYhYNU7G115V6ykS7KaJLJzE3cyeXWDwou7MJdeCcfNTKT1LwzhfkF_m1z6S2CiIuQEJ5z3uScM3KScvKEvOTsDe9a9nb_ed9w3jAtuydkw-VWN71qv52QDVNMNrKX7Sk5Q_zBGK9n9oycCiG41EJuyK-vMMZ7KCu1ucwR80gBKVAX4TZlnKOlc66XIRe6W_B7TLcXSHFNruTJU0iOgis-wUhjwiWEaKNPdn1H43RX8r13FG3xPlUhHdYqoLDMeYKDc5ymJWVAhPU5eRpgRP_iuJ-Tm6v9ze5jc_3lw6fd--tmkH07N0IJ5axmrXVeD7rzQyeCU9Ix2wnhO666unwvrJBBtIMKVoce2mCHQbtte04uHmzr234uHmczRbR-HCH5vKDRfVsnqE5V8tWRXIbJO3NX4lRjMo_RVeD1EQC0MIYCyUb8w3VK9FumK8cfOFsyYvHB2DjX7-c0F4ij4cwcajS1RsO5OdRYNZd_aR5t_00fJwwx4yH-OdYa4L-a33GzsA4 |
CitedBy_id | crossref_primary_10_1186_1472_6823_14_75 crossref_primary_10_1111_cen_13490 crossref_primary_10_1515_cclm_2023_0141 crossref_primary_10_1007_s13631_016_0135_5 crossref_primary_10_1016_j_biopsycho_2024_108892 crossref_primary_10_1007_s13631_016_0113_y crossref_primary_10_1177_0004563218824622 crossref_primary_10_1254_fpj_141_302 crossref_primary_10_3803_EnM_2020_707 crossref_primary_10_1210_clinem_dgaa105 crossref_primary_10_1007_s40292_016_0153_4 crossref_primary_10_1186_s40798_020_00269_4 crossref_primary_10_1097_MED_0000000000000331 crossref_primary_10_1530_EJE_12_0685 crossref_primary_10_3343_alm_2020_40_4_285 crossref_primary_10_1016_j_jad_2012_12_002 crossref_primary_10_1186_s40413_016_0117_0 crossref_primary_10_1016_j_beem_2021_101519 crossref_primary_10_1186_s13098_019_0481_3 crossref_primary_10_1097_MED_0000000000000806 crossref_primary_10_1530_EJE_13_0159 crossref_primary_10_1016_j_ijcard_2015_10_084 crossref_primary_10_1530_EC_18_0085 crossref_primary_10_1007_s13631_015_0088_0 crossref_primary_10_1515_jpem_2017_0270 crossref_primary_10_1007_s12020_013_0129_2 crossref_primary_10_2147_JPR_S252278 crossref_primary_10_4158_EP171887_OR crossref_primary_10_3389_fendo_2022_1075785 crossref_primary_10_1007_s12020_014_0378_8 crossref_primary_10_1210_clinem_dgad763 crossref_primary_10_3390_diagnostics11040728 crossref_primary_10_3390_biomedicines8090314 crossref_primary_10_1007_s11102_012_0397_5 crossref_primary_10_1007_s12020_020_02392_4 crossref_primary_10_1177_0004563216687335 crossref_primary_10_1530_EJE_13_0702 crossref_primary_10_1002_alr_21228 crossref_primary_10_1136_jim_2018_000752 crossref_primary_10_1111_cen_14286 crossref_primary_10_1007_s11154_013_9240_1 crossref_primary_10_1007_s11102_022_01249_5 crossref_primary_10_1007_s13631_015_0078_2 crossref_primary_10_1111_cen_14920 crossref_primary_10_5507_bp_2024_033 crossref_primary_10_1007_s12020_013_0013_0 crossref_primary_10_1016_j_psyneuen_2015_08_016 crossref_primary_10_1186_s13063_016_1347_8 crossref_primary_10_3390_jcm9103233 crossref_primary_10_1210_jc_2019_00304 crossref_primary_10_1016_j_beem_2013_05_015 crossref_primary_10_2174_1573396315666191026100643 crossref_primary_10_1007_s12020_016_0978_6 crossref_primary_10_1016_j_job_2014_06_001 crossref_primary_10_1016_j_ando_2023_10_007 crossref_primary_10_1007_s00761_017_0319_2 crossref_primary_10_1080_07420528_2021_2016796 crossref_primary_10_1007_s40292_018_0288_6 crossref_primary_10_1007_s11102_015_0639_4 crossref_primary_10_1530_EC_18_0257 crossref_primary_10_1155_2019_7251010 crossref_primary_10_1007_s40618_018_0921_1 crossref_primary_10_1210_js_2016_1056 |
Cites_doi | 10.1111/j.1365-2265.2005.02421.x 10.1016/j.cca.2009.11.033 10.1373/49.8.1408 10.1210/jc.2004-2264 10.1373/clinchem.2008.108910 10.1210/jc.2006-1791 10.1210/jc.2008-0139 10.1515/CCLM.2006.244 10.1093/clinchem/43.8.1386 10.1258/acb.2008.008208 10.1210/jc.84.3.878 10.7326/0003-4819-139-3-200308050-00017 10.1016/S0140-6736(03)13492-7 10.1210/jc.2009-1166 10.1093/clinchem/48.1.207 10.1530/EJE-08-0600 10.1530/EJE-09-0517 10.1530/eje.0.1340093 10.1111/j.1365-2265.2008.03381.x 10.1210/jc.2002-021897 10.1055/s-0029-1225630 10.1210/jc.2010-0982 10.1210/jc.2008-0125 10.1258/acb.2007.007119 10.1210/jc.2002-020534 |
ContentType | Journal Article |
Copyright | 2012 European Society of Endocrinology 2015 INIST-CNRS |
Copyright_xml | – notice: 2012 European Society of Endocrinology – notice: 2015 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1530/EJE-11-0945 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
DocumentTitleAlternate | Assay-specific salivary cortisol reference values |
EISSN | 1479-683X |
EndPage | 618 |
ExternalDocumentID | 22214924 25826709 10_1530_EJE_11_0945 |
Genre | Controlled Clinical Trial Journal Article |
GroupedDBID | --- -~X .55 .GJ 0R~ 169 18M 2WC 3O- 4.4 53G 5GY 5RE 5VS 5WD AABZA AACZT AAPGJ AAPXW AAVAP AAWDT ABLYK ABOCM ABPQP ABPTD ABPTK ABSGY ABSQV ABWST ABXZS ACFRR ACGFO ACNCT ACPRK ACUTJ ADBBV ADDZX ADIPN ADQBN ADVEK AENEX AEQTP AFFNX AFGWE AFHIN AFYAG AGQXC AGUTN AI. AJEEA ALMA_UNASSIGNED_HOLDINGS ALXQX ANFBD APJGH BAWUL BCRHZ BTFSW C1A CS3 DIK DU5 E3Z EBS EJD EMOBN F9R GX1 HZ~ IL9 INIJC J5H KOP KQ8 L7B O9- OAUYM OBFPC OBOKY OCZFY OJZSN OK1 OPAEJ OVD OWPYF P2P RHF ROX SJN TBS TCN TEORI TMA TR2 VH1 W8F WOQ X7M ZA5 ZGI ZXP AARHZ AAUAY AAYXX ABDFA ABEJV ABGNP ABIME ABJNI ABMNT ABNHQ ABPIB ABQNK ABVGC ABXVV ADGKP ADMTO ADNBA ADVOB AEMQT AFXAL AGORE AHGBF AHMMS AJBYB AJNCP ATGXG CITATION H13 IQODW NU- CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-b463t-2828dc903cde9b95eb52fd84d0c522e5185518e62c24f23b8fc9f6a3fcbb9d73 |
ISSN | 0804-4643 1479-683X |
IngestDate | Thu Jul 10 17:36:42 EDT 2025 Thu Apr 03 07:01:50 EDT 2025 Mon Jul 21 09:14:45 EDT 2025 Tue Jul 01 04:13:21 EDT 2025 Thu Apr 24 22:57:18 EDT 2025 Sun Jan 07 07:18:52 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Endocrinopathy Corticosteroid Adrenal cortex diseases Steroid hormone Antiinflammatory agent Cushing syndrome Hyperadrenocorticism Cortisol Medical screening Hydrocortisone Glucocorticoid Immunological method Adrenal insufficiency Adrenal hormone Adrenal gland diseases Diagnosis Saliva Endocrinology Tool |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-b463t-2828dc903cde9b95eb52fd84d0c522e5185518e62c24f23b8fc9f6a3fcbb9d73 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | http://dx.doi.org/10.1530/EJE-11-0945 |
PMID | 22214924 |
PQID | 963828858 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_963828858 pubmed_primary_22214924 pascalfrancis_primary_25826709 crossref_citationtrail_10_1530_EJE_11_0945 crossref_primary_10_1530_EJE_11_0945 bioscientifica_primary_10_1530_EJE_11_0945 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-04-01 |
PublicationDateYYYYMMDD | 2012-04-01 |
PublicationDate_xml | – month: 04 year: 2012 text: 2012-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Bristol |
PublicationPlace_xml | – name: Bristol – name: England |
PublicationTitle | European journal of endocrinology |
PublicationTitleAlternate | Eur J Endocrinol |
PublicationYear | 2012 |
Publisher | BioScientifica |
Publisher_xml | – name: BioScientifica |
References | Dorin (17_17752659) 2003; 139 (20_37934287) 2010; 95 (10_35518615) 2009; 161 Cardoso (16_31746579) 2009; 70 (23_23549960) 2007; 92 Schmidt (18_17809027) 2003; 88 Vogeser (11_23126745) 2006; 44 (6_31793921) 2008; 54 Deutschbein (9_35255002) 2009; 41 van Aken (26_17737107) 2003; 49 Beko (12_36156278) 2010; 411 (8_35272673) 2009; 94 (15_19452889) 2005; 90 Raff (21_11451575) 2002; 48 (19_32342951) 2009; 160 (3_30600398) 2008; 93 (4_30600400) 2008; 93 Papanicolaou (22_17269627) 2002; 87 Arlt (1_17660455) 2003; 361 (7_33708272) 2009; 46 (5_32894395) 2006; 27 Castro (14_10754938) 1999; 84 Reynolds (2_21386388) 2006; 64 Barrou (13_16173049) 1996; 134 Wood (25_31334434) 2008; 45 Turpeinen (24_5708013) 1997; 43 |
References_xml | – volume: 64 start-page: 82 issn: 0300-0664 issue: 1 year: 2006 ident: 2_21386388 publication-title: Clinical endocrinology doi: 10.1111/j.1365-2265.2005.02421.x – volume: 411 start-page: 364 issn: 1873-3492 issue: 5-6 year: 2010 ident: 12_36156278 publication-title: Clinica Chimica Acta doi: 10.1016/j.cca.2009.11.033 – volume: 49 start-page: 1408 issn: 0009-9147 issue: 8 year: 2003 ident: 26_17737107 publication-title: Clinical Chemistry doi: 10.1373/49.8.1408 – volume: 90 start-page: 5730 issn: 0021-972X issue: 10 year: 2005 ident: 15_19452889 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.2004-2264 – volume: 54 start-page: 1759 issn: 0009-9147 issue: 11 year: 2008 ident: 6_31793921 publication-title: Clinical Chemistry doi: 10.1373/clinchem.2008.108910 – volume: 92 start-page: 1326 issn: 0021-972X issue: 4 year: 2007 ident: 23_23549960 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.2006-1791 – volume: 93 start-page: 1553 issn: 0021-972X issue: 5 year: 2008 ident: 4_30600400 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.2008-0139 – volume: 44 start-page: 1441 issn: 1434-6621 issue: 12 year: 2006 ident: 11_23126745 publication-title: Clinical chemistry and laboratory medicine : CCLM / FESCC doi: 10.1515/CCLM.2006.244 – volume: 43 start-page: 1386 issn: 0009-9147 issue: 8 year: 1997 ident: 24_5708013 publication-title: Clinical Chemistry doi: 10.1093/clinchem/43.8.1386 – volume: 46 start-page: 183 issn: 0004-5632 issue: 3 year: 2009 ident: 7_33708272 publication-title: Annals of Clinical Biochemistry doi: 10.1258/acb.2008.008208 – volume: 84 start-page: 878 issn: 0021-972X issue: 3 year: 1999 ident: 14_10754938 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.84.3.878 – volume: 139 start-page: 194 issn: 0003-4819 issue: 3 year: 2003 ident: 17_17752659 publication-title: Annals of Internal Medicine doi: 10.7326/0003-4819-139-3-200308050-00017 – volume: 361 start-page: 1881 issn: 0140-6736 issue: 9372 year: 2003 ident: 1_17660455 publication-title: Lancet doi: 10.1016/S0140-6736(03)13492-7 – volume: 94 start-page: 3647 issn: 0021-972X issue: 10 year: 2009 ident: 8_35272673 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.2009-1166 – volume: 48 start-page: 207 issn: 0009-9147 issue: 1 year: 2002 ident: 21_11451575 publication-title: Clinical Chemistry doi: 10.1093/clinchem/48.1.207 – volume: 160 start-page: 9 issn: 0804-4643 issue: 1 year: 2009 ident: 19_32342951 publication-title: European Journal of Endocrinology doi: 10.1530/EJE-08-0600 – volume: 27 start-page: 139 year: 2006 ident: 5_32894395 publication-title: CLINICAL BIOCHEMIST REVIEWS – volume: 161 start-page: 747 issn: 0804-4643 issue: 5 year: 2009 ident: 10_35518615 publication-title: European Journal of Endocrinology doi: 10.1530/EJE-09-0517 – volume: 134 start-page: 93 issn: 0804-4643 issue: 1 year: 1996 ident: 13_16173049 publication-title: European Journal of Endocrinology doi: 10.1530/eje.0.1340093 – volume: 70 start-page: 516 issn: 0300-0664 issue: 4 year: 2009 ident: 16_31746579 publication-title: Clinical endocrinology doi: 10.1111/j.1365-2265.2008.03381.x – volume: 88 start-page: 4193 issn: 0021-972X issue: 9 year: 2003 ident: 18_17809027 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.2002-021897 – volume: 41 start-page: 834 issn: 0018-5043 issue: 11 year: 2009 ident: 9_35255002 publication-title: Hormone and metabolic research. Hormon- und Stoffwechselforschung. Hormones et m tabolisme doi: 10.1055/s-0029-1225630 – volume: 95 start-page: 4855 issn: 0021-972X issue: 11 year: 2010 ident: 20_37934287 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.2010-0982 – volume: 93 start-page: 1526 issn: 0021-972X issue: 5 year: 2008 ident: 3_30600398 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.2008-0125 – volume: 45 start-page: 380 issn: 0004-5632 issue: 4 year: 2008 ident: 25_31334434 publication-title: Annals of Clinical Biochemistry doi: 10.1258/acb.2007.007119 – volume: 87 start-page: 4515 issn: 0021-972X issue: 10 year: 2002 ident: 22_17269627 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.2002-020534 |
SSID | ssj0016430 |
Score | 2.3049412 |
Snippet | BackgroundSalivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific... Salivary cortisol is increasingly used to assess patients with suspected hypo- and hypercortisolism. This study established disease-specific reference ranges... |
SourceID | proquest pubmed pascalfrancis crossref bioscientifica |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 613 |
SubjectTerms | Adrenal Insufficiency - diagnosis Adrenal Insufficiency - metabolism Adrenals. Adrenal axis. Renin-angiotensin system (diseases) Adult Automation Biological and medical sciences Clinical Study Cushing Syndrome - diagnosis Cushing Syndrome - metabolism Diagnostic Techniques, Endocrine - instrumentation Diagnostic Techniques, Endocrine - standards Endocrinopathies Female Fundamental and applied biological sciences. Psychology High-Throughput Screening Assays - instrumentation High-Throughput Screening Assays - methods High-Throughput Screening Assays - standards Humans Hydrocortisone - analysis Hydrocortisone - metabolism Immunoassay - instrumentation Immunoassay - methods Immunoassay - standards Male Medical sciences Middle Aged Non tumoral diseases. Target tissue resistance. Benign neoplasms Prevention and actions Public health. Hygiene Public health. Hygiene-occupational medicine Reference Values ROC Curve Saliva - chemistry Saliva - metabolism Sensitivity and Specificity Vertebrates: endocrinology |
Title | Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay |
URI | http://dx.doi.org/10.1530/EJE-11-0945 https://www.ncbi.nlm.nih.gov/pubmed/22214924 https://www.proquest.com/docview/963828858 |
Volume | 166 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ta9RAEF7OCqKoaOvL-VL2Q1GwpOY2u3uJ39p6UioVxRP6LewmGwnIpdwlH84_4E_xbzqzu7kkWMX64cIRdvPCPJmdmZ15hpA9WNVzJpgIwmLKA15I3CTMZWAijgxmJhN2R_fsgzz5wk_Pxflo9LOXtdTU-iD7fmldyf9IFc6BXLFK9gqS3VwUTsB_kC8cQcJw_CcZf1a4kbNc74MLWZdwL-waozCeiulzSMVaI8UmZhIeNzbWZMPzLUuBI2rFUm7LvLFqLJ0E1mJinKC04QawR0GxgLOLIQWNZE37qqkrR_RaYnFJBea3GmwODyL83to1i7wCBTWM4r81TQ3etfYNNxE3vfCAwYyP4OPSNK6xu2M8UB3iSpxsYYjb_UfSc3VZ5gDz1bfpxoRN1Y9tYJII78c2jsrKajibNaX6mhHGcen4nQ6M09x8mgQyts2FO9XuOrp4DPOeopaTqLfmS7cG_LaciAjzL2enM1t9mHBxjVxn4I9gq4z3n7rtKngUG8xrn8sXgsL0173Jt8gdXTqKUvdGA1vo9oVawWdZuH4qf3Z4rOEzv0fueo-FHjr43Scjs9gmO4cLBShY0xfU5hBbsW6TG2c-VWOH_GjBSVtwUrWiinbgpAhOCuCkHpwvV7SFJgVoUg9NOoDmG9oCk26ASfUaJtANMGkPmA_I_N1sfnwS-K4fgeYyqgOMAeRZEkZZbhKdCKMFK_KY52EGvoIRYGDCz0iWMV6wSMdFlhRSRUWmdZJPo4dka1EtzGNCjRFahGZqRDLhGVjmuSoiOLB8kpiwkGPyaiiP9MIxvKToGYPwUhAeuMgpCg8Gt7JKM0-fj11cvl0-eG8z-K_X3B0IfTOWCfD6p2EyJrRFQQpqH_fy1MJUzSrFdZPFsYjH5JFDRzeZsQlPGH9yldd7Sm52H-AzslUvG_MczO1a71qo_wKek9xt |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Salivary+cortisol+as+a+diagnostic+tool+for+Cushing%27s+syndrome+and+adrenal+insufficiency%3A+improved+screening+by+an+automatic+immunoassay&rft.jtitle=European+journal+of+endocrinology&rft.au=Deutschbein%2C+Timo&rft.au=Broecker-Preuss%2C+Martina&rft.au=Flitsch%2C+J%C3%B6rg&rft.au=Jaeger%2C+Andrea&rft.date=2012-04-01&rft.pub=BioScientifica&rft.issn=0804-4643&rft.eissn=1479-683X&rft.volume=166&rft.issue=4&rft.spage=613&rft.epage=618&rft_id=info:doi/10.1530%2FEJE-11-0945 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0804-4643&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0804-4643&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0804-4643&client=summon |